Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
|
Results for 'Forecast Insight: Opioids' |
|
|
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Opioids Market to 2017 Steady Uptake of Oxycontin and High Incidence of Diseases Such as Cancer and Arthritis to Drive The Market |
Jun 2011 | £2,215 | 100% |
| Pipeline Insight: Breakthrough Pain Fast-acting players will capture majority market share |
Nov 2006 | £7,210 | 98% |
| The Global Pain Therapeutics Market 4th Edition: Market Trends & R&D Insights |
Nov 2010 | £1,105 | 92% |
| World Market for Addiction Disorders, 2009-2016 The Future Therapies for Substance Dependence and Impulse Control |
Oct 2009 | £1,495 | 88% |
| Stakeholder Insight: Cancer Pain Physician survey highlights inadequacies in education and treatment |
Dec 2009 | £9,615 | 87% |
| Cancer Pain Therapeutics Pipeline Assessment and Market Forecasts to 2017 |
Apr 2011 | £1,265 | 84% |
| Acute Pain Therapeutics Pipeline Assessment and Market Forecasts to 2017 |
Mar 2011 | £1,265 | 80% |
| Migraine Therapeutics Pipeline Assessment and Market Forecasts to 2016 |
Jul 2010 | £1,265 | 65% |
| Neuropathic Pain Drug Pipeline Analysis and Market Forecasts to 2015 |
Dec 2009 | £1,265 | 60% |
| Osteoarthritis (OA) Therapeutics Pipeline Assessment and Market Forecasts to 2018 |
Nov 2011 | £2,215 | 58% |
| Addiction Control Therapeutics Pipeline Assessment and Market Forecasts to 2018 |
Dec 2011 | £2,215 | 58% |
| Neuropathic Pain - Pipeline Assessment and Market Forecasts to 2016 | Jul 2010 | £1,265 | 57% |
| Hepatitis C (HCV) Market Forecast & Drugs Pipeline Analysis to 2016 | Jan 2011 | £680 | 55% |
| The Global Market for Pain Management Drugs and Devices | Aug 2009 | £3,065 | 52% |
| Rimonabant: The first of the Cannabinoid blockbusters | Jun 2007 | £1,499 | 48% |
| Cancer Supportive Care Products Market to 2016 Market is Expected to Decline after 2014 Due to Generic Erosion and Entry of Biosimilars |
Apr 2011 | £2,215 | 47% |
| Top 10 Healthcare Trends in 2011 | Mar 2011 | £2,215 | 47% |
| Advanced Oral & Parenteral Drug Delivery Technologies Players, Products & Prospects to 2015 |
Jan 2011 | £995 | 44% |
| Neurodegenerative Disease Drug Market Analysis and Forecasts 2007 | Jun 2007 | £1,999 | 44% |
| Pain Management Therapeutics Market to 2017 Price Competition to Intensify Following Patent Expiries of Lyrica and Cymbalta |
Nov 2011 | £2,215 | 43% |
- Results 1 - 20 of 20
-
-
- 1
-
-
